124 related articles for article (PubMed ID: 7787133)
1. Disposition of [3H]fluvastatin following single oral doses in beagle dogs and rhesus monkeys with bile fistulae.
Tse FL; Dain JG; Kalafsky G
Biopharm Drug Dispos; 1995 Apr; 16(3):211-9. PubMed ID: 7787133
[TBL] [Abstract][Full Text] [Related]
2. Disposition of fluvastatin, an inhibitor of HMG-COA reductase, in mouse, rat, dog, and monkey.
Tse FL; Smith HT; Ballard FH; Nicoletti J
Biopharm Drug Dispos; 1990; 11(6):519-31. PubMed ID: 2207302
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers.
Tse FL; Jaffe JM; Troendle A
J Clin Pharmacol; 1992 Jul; 32(7):630-8. PubMed ID: 1640002
[TBL] [Abstract][Full Text] [Related]
4. The safety evaluation of fluvastatin, an HMG-CoA reductase inhibitor, in beagle dogs and rhesus monkeys.
Hartman HA; Myers LA; Evans M; Robison RL; Engstrom RG; Tse FL
Fundam Appl Toxicol; 1996 Jan; 29(1):48-62. PubMed ID: 8838639
[TBL] [Abstract][Full Text] [Related]
5. Regional intestinal absorption and biliary excretion of fluvastatin in the rat: possible involvement of mrp2.
Lindahl A; Sjöberg A; Bredberg U; Toreson H; Ungell AL; Lennernäs H
Mol Pharm; 2004; 1(5):347-56. PubMed ID: 16026004
[TBL] [Abstract][Full Text] [Related]
6. Absorption and disposition of fluvastatin, an inhibitor of HMG-CoA reductase, in the rabbit.
Tse FL; Labbadia D
Biopharm Drug Dispos; 1992 May; 13(4):285-94. PubMed ID: 1600114
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the pharmacokinetic interaction between fluvastatin XL and cyclosporine in renal transplant recipients.
Holdaas H; Hagen E; Asberg A; Lund K; Hartman A; Vaidyanathan S; Prasad P; He YL; Yeh CM; Bigler H; Rouilly M; Denouel J
Int J Clin Pharmacol Ther; 2006 Apr; 44(4):163-71. PubMed ID: 16625985
[TBL] [Abstract][Full Text] [Related]
8. Dose dependency of fluvastatin pharmacokinetics in serum determined by reversed phase HPLC.
Siekmeier R; Lattke P; Mix C; Park JW; Jaross W
J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):137-45. PubMed ID: 11509920
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of fluvastatin.
Scripture CD; Pieper JA
Clin Pharmacokinet; 2001; 40(4):263-81. PubMed ID: 11368292
[TBL] [Abstract][Full Text] [Related]
10. Effects of alcohol consumption on pharmacokinetics, efficacy, and safety of fluvastatin.
Smit JW; Wijnne HJ; Schobben F; Sitsen A; de Bruin TW; Erkelens DW
Am J Cardiol; 1995 Jul; 76(2):89A-96A. PubMed ID: 7604808
[TBL] [Abstract][Full Text] [Related]
11. Development and pharmacology of fluvastatin.
Jokubaitis LA
Br J Clin Pract Suppl; 1996 Jan; 77A():11-5. PubMed ID: 8729584
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of the biopharmaceutical properties of fluvastatin.
Deslypere JP
Am J Cardiol; 1994 May; 73(14):12D-17D. PubMed ID: 8198018
[TBL] [Abstract][Full Text] [Related]
13. Development and pharmacology of fluvastatin.
Jokubaitis LA
Br J Clin Pract Suppl; 1994 Dec; (77):11-5. PubMed ID: 19489169
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
[TBL] [Abstract][Full Text] [Related]
15. Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin.
Kivistö KT; Kantola T; Neuvonen PJ
Br J Clin Pharmacol; 1998 Jul; 46(1):49-53. PubMed ID: 9690949
[TBL] [Abstract][Full Text] [Related]
16. Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.
Dujovne CA; Davidson MH
Am J Med; 1994 Jun; 96(6A):37S-40S. PubMed ID: 8017465
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective analysis of fluvastatin in human plasma for pharmacokinetic studies.
Lanchote VL; Rocha A; de Albuquerque FU; Coelho EB; Bonato PS
J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):81-8. PubMed ID: 11817313
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of fluvastatin and specific drug interactions.
Smith HT; Jokubaitis LA; Troendle AJ; Hwang DS; Robinson WT
Am J Hypertens; 1993 Nov; 6(11 Pt 2):375S-382S. PubMed ID: 8297546
[TBL] [Abstract][Full Text] [Related]
19. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.
Mattiuz E; Franklin R; Gillespie T; Murphy A; Bernstein J; Chiu A; Hotten T; Kassahun K
Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of a new positive inotropic agent, 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), in the rat, rabbit, beagle dog and rhesus monkey.
Miyamoto G; Sasabe H
Arzneimittelforschung; 1984; 34(3A):394-402. PubMed ID: 6540095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
